Some but not all randomized controlled trials (RCT) have suggested that percutaneous coronary intervention (PCI) with drug-eluting stents may be an acceptable alternative to coronary artery bypass grafting (CABG) surgery for the treatment of unprotected left main coronary artery disease (ULMCAD). We therefore aimed to compare the risk of all-cause mortality between PCI and CABG in patients with ULMCAD in a pairwise meta-analysis of RCT. METHODS: Randomized controlled trials comparing PCI vs CABG for the treatment of ULMCAD were searched through MEDLINE, EMBASE, Cochrane databases, and proceedings of international meetings. RESULTS: Six trials including 4,686 randomized patients were identified. After a median follow-up of 39 months, there were no significant differences between PCI vs CABG in the risk of all-cause mortality (hazard ratio [HR] 0.99, 95% CI 0.76-1.30) or cardiac mortality. However, a significant interaction for cardiac mortality (Pinteraction= .03) was apparent between randomization arm and SYNTAX score, such that the relative risk for mortality tended to be lower with PCI compared with CABG among patients in the lower SYNTAX score tertile, similar in the intermediate tertile, and higher in the upper SYNTAX score tertile. Percutaneous coronary intervention compared with CABG was associated with a similar long-term composite risk of death, myocardial infarction, or stroke (HR 1.06, 95% CI 0.82-1.37), with fewer events within 30 days after PCI offset by fewer events after 30 days with CABG (Pinteraction < .0001). Percutaneous coronary intervention was associated with greater rates of unplanned revascularization compared with CABG (HR 1.74, 95% CI 1.47-2.07). CONCLUSIONS: In patients undergoing revascularization for ULMCAD, PCI was associated with similar rates of mortality compared with CABG at a median follow-up of 39 months, but with an interaction effect suggesting relatively lower mortality with PCI in patients with low SYNTAX score and relatively lower mortality with CABG in patients with high SYNTAX score. Both procedures resulted in similar long-term composite rates of death, myocardial infarction, or stroke, with PCI offering an early safety advantage and CABG demonstrating greater durability.

Clinical outcomes with percutaneous coronary revascularization vs coronary artery bypass grafting surgery in patients with unprotected left main coronary artery disease. A meta-analysis of 6 randomized trials and 4,686 patients / Palmerini, Tullio; Serruys, Patrick; Kappetein, Arie Pieter; Genereux, Philippe; Riva, Diego Della; Reggiani, Letizia Bacchi; Christiansen, Evald; Holm, Niels R.; Thuesen, Leif; Makikallio, Timo; Morice, Marie Claude; Ahn, Jung-Min; Park, Seung-Jung; Thiele, Holger; Boudriot, Enno; Sabatino, Mario; Romanello, Mattia; Biondi-Zoccai, Giuseppe; Cavalcante, Raphael; Sabik, Joseph F.; Stone, Gregg W.. - In: AMERICAN HEART JOURNAL. - ISSN 0002-8703. - 190:(2017), pp. 54-63. [10.1016/j.ahj.2017.05.005]

Clinical outcomes with percutaneous coronary revascularization vs coronary artery bypass grafting surgery in patients with unprotected left main coronary artery disease. A meta-analysis of 6 randomized trials and 4,686 patients

Biondi-Zoccai, Giuseppe;
2017

Abstract

Some but not all randomized controlled trials (RCT) have suggested that percutaneous coronary intervention (PCI) with drug-eluting stents may be an acceptable alternative to coronary artery bypass grafting (CABG) surgery for the treatment of unprotected left main coronary artery disease (ULMCAD). We therefore aimed to compare the risk of all-cause mortality between PCI and CABG in patients with ULMCAD in a pairwise meta-analysis of RCT. METHODS: Randomized controlled trials comparing PCI vs CABG for the treatment of ULMCAD were searched through MEDLINE, EMBASE, Cochrane databases, and proceedings of international meetings. RESULTS: Six trials including 4,686 randomized patients were identified. After a median follow-up of 39 months, there were no significant differences between PCI vs CABG in the risk of all-cause mortality (hazard ratio [HR] 0.99, 95% CI 0.76-1.30) or cardiac mortality. However, a significant interaction for cardiac mortality (Pinteraction= .03) was apparent between randomization arm and SYNTAX score, such that the relative risk for mortality tended to be lower with PCI compared with CABG among patients in the lower SYNTAX score tertile, similar in the intermediate tertile, and higher in the upper SYNTAX score tertile. Percutaneous coronary intervention compared with CABG was associated with a similar long-term composite risk of death, myocardial infarction, or stroke (HR 1.06, 95% CI 0.82-1.37), with fewer events within 30 days after PCI offset by fewer events after 30 days with CABG (Pinteraction < .0001). Percutaneous coronary intervention was associated with greater rates of unplanned revascularization compared with CABG (HR 1.74, 95% CI 1.47-2.07). CONCLUSIONS: In patients undergoing revascularization for ULMCAD, PCI was associated with similar rates of mortality compared with CABG at a median follow-up of 39 months, but with an interaction effect suggesting relatively lower mortality with PCI in patients with low SYNTAX score and relatively lower mortality with CABG in patients with high SYNTAX score. Both procedures resulted in similar long-term composite rates of death, myocardial infarction, or stroke, with PCI offering an early safety advantage and CABG demonstrating greater durability.
2017
cause of death; coronary artery bypass; coronary artery disease; global health; humans; incidence; percutaneous coronary intervention; postoperative complications; survival rate; drug-eluting stents; randomized controlled trials as topic; cardiology and cardiovascular medicine
01 Pubblicazione su rivista::01a Articolo in rivista
Clinical outcomes with percutaneous coronary revascularization vs coronary artery bypass grafting surgery in patients with unprotected left main coronary artery disease. A meta-analysis of 6 randomized trials and 4,686 patients / Palmerini, Tullio; Serruys, Patrick; Kappetein, Arie Pieter; Genereux, Philippe; Riva, Diego Della; Reggiani, Letizia Bacchi; Christiansen, Evald; Holm, Niels R.; Thuesen, Leif; Makikallio, Timo; Morice, Marie Claude; Ahn, Jung-Min; Park, Seung-Jung; Thiele, Holger; Boudriot, Enno; Sabatino, Mario; Romanello, Mattia; Biondi-Zoccai, Giuseppe; Cavalcante, Raphael; Sabik, Joseph F.; Stone, Gregg W.. - In: AMERICAN HEART JOURNAL. - ISSN 0002-8703. - 190:(2017), pp. 54-63. [10.1016/j.ahj.2017.05.005]
File allegati a questo prodotto
File Dimensione Formato  
Palmerini_Clinical-outcomes_2017.pdf

solo gestori archivio

Tipologia: Versione editoriale (versione pubblicata con il layout dell'editore)
Licenza: Tutti i diritti riservati (All rights reserved)
Dimensione 919.59 kB
Formato Adobe PDF
919.59 kB Adobe PDF   Contatta l'autore

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11573/1085935
Citazioni
  • ???jsp.display-item.citation.pmc??? 21
  • Scopus 75
  • ???jsp.display-item.citation.isi??? 64
social impact